Navigation Links
LA BioMed researcher honored for research paper
Date:9/3/2014

LOS ANGELES (Sept. 3, 2014) The North American Menopause Society (NAMS) will present Los Angeles Biomedical Research Institute (LA BioMed) researcher Rowan T. Chlebowski, MD, PhD, with the 2014 NAMS Lippincott/Williams & Wilkins Menopause Journal Best Paper Award at its annual meeting in Washington, D.C. in October.

The organization, which is dedicated to promoting the health and quality of life of all women during midlife and beyond, will recognize Dr. Chlebowski for his article, "Estrogen alone and joint symptoms in the Women's Health Initiative randomized trial."

This article was selected from all articles published in 2013, and the presentation of the award will take place at the NAMS 2014 Annual Meeting Oct. 15-18.

"Congratulations to Dr. Chlebowski for this honor for his scholarship and research," said David I. Meyer, PhD, LA BioMed president and CEO. "Dr. Chlebowski is a leader in both cancer prevention and women's health. The article, which won the award, is one of several significant studies he has authored or co-authored from the Women's Health Initiative, one of the largest U.S. prevention studies of its kind."

In addition to his research at LA BioMed, Dr. Chlebowski is the chief of Medical Oncology and Hematology at the Harbor-UCLA Medical Center and a professor of medicine at the UCLA David Geffen School of Medicine. He earned his doctorate degree in reproductive biology at Case Western Reserve University, where he also earned his medical degree.

After an internship and residency in internal medicine at Cleveland Metropolitan General Hospital, Dr. Chlebowski's fellowship brought him to the University of Southern California's School of Medicine. He has held positions in the UCLA health system since 1979.

Recently, Dr. Chlebowski has been best known for his work on significant clinical trials related to breast cancer prevention and therapy and women's health. He reported results of the Women's Intervention Nutrition Study, a multicenter adjuvant trial where a lifestyle intervention reduced breast cancer recurrence, at the 2005 American Society of Clinical Oncology (ASCO) Annual Meeting Plenary Session.

As a Women's Health Initiative investigator, Dr. Chlebowski led reports on estrogen alone and estrogen plus progestin influence on cancer endpoints. The findings have substantially changed clinical use of menopausal hormone therapy worldwide with an associated reduction in breast cancer incidence. He was also the recipient of the 2012 ASCO/American Cancer Society Award.


'/>"/>

Contact: Laura Mecoy
Lmecoy@labiomed.org
310-546-5860
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Source:Eurekalert  

Related medicine news :

1. Drexel College of Medicine’s Graduate School of Biomedical Sciences & Professional Studies to Host Conference to Help Graduate Students Find Careers Beyond the Bench
2. University of Nevada, Reno continues $10 million biomedical studies for COBRE grant
3. UMMS scientist named 2014 Pew Latin American Fellow in the biomedical sciences
4. Endocrine Society honors Sen. Dick Durbin with Biomedical Research Champion Award
5. Tufts University licenses silk biomaterials technology to Akeso Biomedical
6. LA BioMed researchers report on promising new therapy for devastating genetic disorder
7. Pitts Center for Medical Innovation announces pilot funding for biomedical technology
8. New biomedical diagnostics using personalized 3-D imaging
9. NCCS and Clearbridge Biomedics open the regions first circulating tumor cell center
10. LA BioMed study finds daily antibiotics most effective in preventing recurrent urinary tract infection
11. A New Player In Biomedical Equipment Opens Headquarters in San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
LA BioMed researcher honored for research paper
(Date:5/27/2016)... ... 27, 2016 , ... With a team of certified experts, ... Aside from its GMP accreditation, Validation Center is also a registered authority of ... and staff. , Validation Center is ISO17025 accredited and only offers its clients ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... and clinical outcomes, hosted members and suppliers for its inaugural Member Conference at ... on their mission of elevating the operational health of America’s healthcare providers. , ...
(Date:5/26/2016)... ... 2016 , ... Cardiac arrhythmia is a common complication following ... survival, reports a team of UPMC researchers in the largest study of its ... Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead to better ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... An April ... American families. , The 550 employees of Sun Health Senior Living (SHSL) ... Aetna that reduces their doctor and prescription copays for the year, while holding the ...
(Date:5/26/2016)... ... ... The Lung Institute has partnered with the Gulfcoast North Area ... at their clinic in downtown Tampa. The class is complimentary for the public. Register ... a free downloadable 4 Week Smoking Cessation Guide for those who are ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... May 24, 2016 Niederländische ... gebracht, die es Ärzten erlaubt, ihre Expertise weltweit ... MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion und ... kommunizieren. Mediziner in Europa, Afrika, Asien und den ... für die Plattform registriert. Information und ...
(Date:5/24/2016)...   , Study met both ... in , Excellent plus Good ... of the ascending colon   ,      ... announced new positive data from the phase III MORA study for ... litre PEG with ascorbate. The study met both primary endpoints showing ...
(Date:5/24/2016)... 2016  NxStage Medical, Inc. (Nasdaq: NXTM ... renal care, today announced that Jeffrey H. Burbank ... following schedule of investor conferences. Where applicable, a webcast ... http://ir.nxstage.com/ .   ... NY           Friday, June 10, 2016 1:30 p.m. ET ...
Breaking Medicine Technology: